(Press-News.org)
A common cause of myocardial infarction and stroke is the rupture of atherosclerotic plaques. The exact location of plaque ruptures has previously been unknown, but now researchers at Lund University have mapped this. The research team has also identified an enzyme, a marker, that they hope will help predict who is at risk of having a myocardial infarction or a stroke due to a ruptured atherosclerotic plaque.
In atherosclerosis , fat is accumulated in the artery walls creating atherosclerotic plaques. Plaques that rupture can cause a stroke or myocardial infarction, and a deeper understanding of the mechanisms underlying plaque rupture is needed to prevent serious complications. Research at Lund University, Sweden,now shows that atherosclerotic plaques in the carotid arteries often rupture at the beginning of the plaque, at a location closest to the heart. The study has been published in the Journal of the American College of Cardiology (JACC).
“In our study, we were able to pinpoint exactly where plaques rupture. This is an important step, allowing for a better understanding of why they rupture. Previous studies have focused more on how plaques are formed while we have studied the precise area where they rupture, which no previous human study has done”, says Isabel Goncalves, who led the study.
Important patient groups
She is professor of cardiology at Lund University and a senior consultant at Skåne University Hospital (SUS) in Sweden. The research is based on studies of atherosclerotic plaques in the carotid arteries from a total of 188 individuals. The researchers used electron microscope and RNA sequencing techniques to get a detailed picture of the location where most plaques rupture. High blood pressure and type 2 diabetes are factors that increase the risk of atherosclerosis and therefore these patient groups were also included in the study.
“One of the strengths of our study is that it’s based on a close collaboration between clinically active researchers and experts in bioinformatics. We have also used several different techniques to allow as detailed analyses as possible. It was important to us to include people with type 2 diabetes in the study as this is a group with high risk of dying from complications related to atherosclerosis compared to the rest of the population”, says Jiangming Sun, researcher in bioinformatics at Lund University and first author of the paper.
Marker for complications
The RNA sequencing showed a strong association between the enzyme MMP-9 and the area where plaques rupture. High levels of MMP-9 could also be associated with an increased risk of future cardiovascular disease in individuals with atherosclerosis. The researchers hope to be able to use MMP-9 as a marker to predict which patients are at risk of having a myocardial infarction or a stroke. They are also investigating if it is possible to develop new treatments that reduce the risk of plaque rupture.
“Our study shows that MMP-9 is a marker of future cardiovascular complications. In further studies, we want to investigate if it’s possible to inhibit the enzyme, so it becomes less active and thus prevent plaque rupture. However, it’s important that such treatment does not lead to unwanted side effects as the enzyme has other important functions in the body”, says Isabel Goncalves.
Preventive measures
For several years, Isabel Goncalves has worked to learn more about what happens when plaques rupture together with her clinically active research colleague Andreas Edsfeldt at Lund University, also a physician at Skåne University Hospital. As physicians, they see a lot of patients they would like to help at an earlier stage than what is possible today.
“We see a lot of patients who have had a heart attack or have become partially paralysed following a stroke and can no longer live life as they used to. Often, atherosclerosis does not cause symptoms at an early stage so it can take years before the disease is noticed. Sadly, those of us who work clinically discover the plaque too late, when it has already ruptured and caused serious complications like sudden death, heart attack or a stroke. If we can learn more about the underlying mechanisms, we can initiate preventive measures or treat the dangerous plaques in time”, says Isabel Goncalves.
END
CHAMPAIGN, Ill. — Researchers have detected complex organic molecules in a galaxy more than 12 billion light-years away from Earth – the most distant galaxy in which these molecules are now known to exist. Thanks to the capabilities of the recently launched James Webb Space Telescope and careful analyses from the research team, a new study lends critical insight into the complex chemical interactions that occur in the first galaxies in the early universe.
University of Illinois Urbana-Champaign astronomy and physics professor Joaquin Vieira and graduate student Kedar Phadke collaborated with researchers at Texas A&M ...
As the Co-Editors-in-Chief of Zoonoses, Dr. Lynn Soong (University of Texas Medical Branch, TX, USA) and Dr. Xiaoping Dong (Chinese Center for Disease Control & Prevention, Beijing, China) extend a warm welcome to Dr. Fernando Rosado Spilki, new Executive Editor-in-Chief (Vector Biology/Epidemiology) of Zoonoses.
Dr. Spilki is currently a Professor in the Institute of Health Sciences at Feevale University, Novo Hamburgo, Brazil. He received B.S. in Veterinary Medicine (2001), M.S. in Veterinary Sciences/Animal Virology (2004) both from the Universidade Federal do Rio Grande do Sul, and his Ph.D. in Genetics & Molecular ...
Fungi stores a third of carbon from fossil fuel emissions and could be essential to reaching net zero, new study reveals
Mycorrhizal fungi are responsible for holding up to 36 per cent of yearly global fossil fuel emissions below ground - more than China emits each year
The fungi make up a vast underground network all over the planet underneath grasslands and forests, as well as roads, gardens, and houses on every continent on Earth
It is not only crucial to storing carbon and keeping the planet cooler, but are also essential to global biodiversity
Researchers ...
Industrialised nations responsible for excessive levels of carbon dioxide emissions could be liable to pay a total of $170 trillion in compensation or reparations by 2050 to ensure climate change targets are met, say researchers.
This money, which amounts to nearly $6 trillion per year or about 7% of annual global Gross Domestic Product (GDP), would be distributed as compensation to low-emitting countries that must decarbonise their economies far more rapidly than would otherwise be required.
Financial redress for the losses and damages that climate-vulnerable countries face due to the excessive CO2 emissions of others is seen as an increasingly important ...
Kim Kaplan
301-588-5314
Kim.Kaplan@usda.gov
BRIDGEcereal: Self-Teaching Web App Improves Speed, Accuracy of Classifying DNA Variations Among Cereal Varieties
PULLMAN, WA, June 5, 2023—Agricultural Research Service and Washington State University scientists have developed an innovative web app called BRIDGEcereal [https://bridgecereal.scinet.usda.gov/] that can quickly and accurately analyze the vast amount of genomic data now available for cereal crops and organize the material into intuitive charts that identify patterns locating genes of interest.
With the rapid advancements in ...
About The Study: This survey study found that 28% of youth-serving U.S. mental health facilities offered LGBTQ-specific mental health services in 2020. Although some states had relatively high levels of LGBTQ service availability as a percentage of facilities, many of these states had few facilities available to children per capita. Public mental health facilities were less likely to offer LGBTQ-specific mental health services, a concern given that the cost of care is a barrier to services. The findings suggest a need to expand availability of LGBTQ services ...
New research has revealed being active could lower the risk of type 2 diabetes, even in people with a high genetic risk of developing the medical condition.
The University of Sydney-led study found higher levels of total physical activity, especially moderate- to vigorous-intensity physical activity, had a strong association with a lower risk of developing type 2 diabetes.
The findings were published in the British Journal of Sports Medicine.
The researchers say the study demonstrates higher levels of physical activity should be promoted as a major strategy for type 2 diabetes ...
Researchers who lead the world’s first comprehensive sequencing program for newborn infants have published the next chapter in the ongoing study of the BabySeq Project, with new findings on infants and families who have been followed for 3-5 years. In a study published today in the American Journal of Human Genetics, researchers from Mass General Brigham and Boston Children’s Hospital reported that over 10 percent of the first 159 infants to undergo screening through DNA sequencing were discovered ...
DURHAM, N.C. – Tirzepatide, a drug approved for diabetes and on the fast track for approval as a weight loss therapy, works through a unique ability to activate two different mechanisms the body uses to control insulin secretion and energy balance, Duke Health researchers report.
The finding, reported June 5 in the journal Nature Metabolism, is the first study to use cells from human donors to demonstrate how tirzepatide stimulates insulin secretion, an important action utilized by this drug to lower blood glucose in patients with type 2 diabetes.
“Understanding the potential of drugs ...
CHICAGO – Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric antigen receptor (CAR) T cell therapy axicabtagene ciloleucel (axi-cel) when compared to the current standard-of-care chemoimmunotherapy, according to results of the Phase III ZUMA-7 trial reported by researchers from The University of Texas MD Anderson Cancer Center.
Data from the study were presented today by Jason Westin, M.D., director of clinical research in the Department of Lymphoma and Myeloma, at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting and published concurrently in ...
